Your browser doesn't support javascript.
loading
Long-term mortality assessment of multidrug-resistant tuberculosis patients treated with delamanid.
Wells, Charles D; Gupta, Rajesh; Hittel, Norbert; Geiter, Lawrence J.
Affiliation
  • Wells CD; Otsuka Pharmaceutical Development and Commercialization, Rockville, MD, USA charles.wells@otsuka-us.com.
  • Gupta R; Otsuka Pharmaceutical Development and Commercialization, Rockville, MD, USA.
  • Hittel N; Otsuka Novel Products, Munich, Germany.
  • Geiter LJ; Otsuka Pharmaceutical Development and Commercialization, Rockville, MD, USA.
Eur Respir J ; 45(5): 1498-501, 2015 May.
Article in En | MEDLINE | ID: mdl-25700385
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oxazoles / Tuberculosis, Multidrug-Resistant / Nitroimidazoles Type of study: Clinical_trials / Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: Eur Respir J Year: 2015 Document type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oxazoles / Tuberculosis, Multidrug-Resistant / Nitroimidazoles Type of study: Clinical_trials / Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: Eur Respir J Year: 2015 Document type: Article Affiliation country: United States